Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.

6 Jul 2021

Keeping Medical Environments Safe, Sterile, and Protected from VOC Exposure

Medical environments, whether that’s the development, manufacture or packing of pharmaceuticals and medical equipment, must be monitored to the highest levels to ensure complete compliance and safety for staff and end-users. ION Science’s range of fixed PID sensors can measure VOC outputs on multiple large sites or single key areas, using world-leading gas detection technology.

From ION Science 6 Jul 2021

Developing a face mask that can detect COVID-19

A face mask has been developed that can detect COVID-19. News-Medical spoke to the researchers behind this idea to find out more about how it works.

6 Jul 2021

COVAX urges equal recognition of all COVID-19 vaccines

COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade.

5 Jul 2021

Researchers develop innovative hearing contact lens for people with hearing impairment

Excessive noise, hearing loss, vascular constriction, old age - hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new, innovative hearing aid with an integrated loudspeaker that sits directly on the eardrum.

2 Jul 2021

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents for humans, animals, and plants, today announced a non-exclusive license agreement granting Nippon Gene access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

1 Jul 2021

Small biotech companies join with pharmaceutical giants to manufacture drugs

Many of the most promising new molecules to treat diseases come from smaller biotechnology firms, which often lack resources to scale up production when it's time for their drugs to go to large-scale clinical trials or the market.

30 Jun 2021

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.

30 Jun 2021

EORTC partners with Pierre Fabre to support patients with stage 2 melanoma

European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma.

29 Jun 2021

Researchers develop smart wound dressings with built-in healing sensors

Researchers have developed smart wound dressings with built-in nanosensors that glow to alert patients when a wound is not healing properly.

28 Jun 2021

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma.

25 Jun 2021

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.

25 Jun 2021

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

Muscular dystrophies are a group of genetic diseases that lead to the progressive loss of muscle mass and function in patients, with the incurable Duchenne Muscular Dystrophy (DMD), which affects all the body's muscles primarily in boys, being particularly severe.

25 Jun 2021

New dietary fiber formulation improves the potency of cancer immunotherapies

Many people don't realize that the trillions of bacteria, viruses, and fungi residing within the gastrointestinal tract--collectively called the gut microbiome-- are connected to overall health, and specifically to cancer.

24 Jun 2021

WHO, COVAX partners work with South African consortium to build COVID-19 vaccine technology transfer hub

The World Health Organization and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention (CDC) to establish its first COVID mRNA vaccine technology transfer hub.

24 Jun 2021

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

A new preprint released on the medRxiv* server explores a link between immunity to SARS-CoV-2, the earlier SARS-CoV, and childhood poliovirus vaccination. Almost 90% of the world’s people have received this vaccine, but antibodies elicited by it reduce over time and are almost absent at the end of adolescence.

24 Jun 2021

Scientists use new technology to optimize drug development for brain diseases

Dr. Hayder Amin and Dr. Caghan Kizil from the DZNE's Dresden site aim to speed up developing drugs against brain diseases through cutting-edge technology.

24 Jun 2021

AI system can rapidly identify healthy, productive skin stem cells

Stem cell therapy is at the cutting edge of regenerative medicine, but until now researchers and clinicians have had to painstakingly evaluate stem cell quality by looking at each cell individually under a microscope.

23 Jun 2021

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

Repligen Corporation today announced that it has entered into an agreement to acquire Toulouse, France-based Polymem S.A., a leading industrial expert.

23 Jun 2021

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).

23 Jun 2021

Manufacturing News and Research

Further Reading

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Keeping Medical Environments Safe, Sterile, and Protected from VOC Exposure

Developing a face mask that can detect COVID-19

COVAX urges equal recognition of all COVID-19 vaccines

Researchers develop innovative hearing contact lens for people with hearing impairment

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

Small biotech companies join with pharmaceutical giants to manufacture drugs

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

EORTC partners with Pierre Fabre to support patients with stage 2 melanoma

Researchers develop smart wound dressings with built-in healing sensors

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

New dietary fiber formulation improves the potency of cancer immunotherapies

WHO, COVAX partners work with South African consortium to build COVID-19 vaccine technology transfer hub

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Scientists use new technology to optimize drug development for brain diseases

AI system can rapidly identify healthy, productive skin stem cells

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News